SIMECKOVA, Pavlina, Frantisek HUBATKA, Jan KOTOUCEK, Pavlina KNOTIGOVA TURANEK, Josef MASEK, Josef SLAVIK, Ondrej KOVAC, Jiri NECA, Pavel KULICH, Dominik HREBÍK, Jana STRASKA, Katerina PENCIKOVA, Jirina PROCHAZKOVA, Pavel DIVIS, Stuart MACAULAY, Robert MIKULÍK, Milan RASKA, Miroslav MACHALA and Jaroslav TURÁNEK. Gadolinium labelled nanoliposomes as the platform for MRI theranostics: in vitro safety study in liver cells and macrophages. Scientific reports. LONDON: NATURE PUBLISHING GROUP, vol. 10, No 1, p. 1-13. ISSN 2045-2322. doi:10.1038/s41598-020-60284-z. 2020.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Gadolinium labelled nanoliposomes as the platform for MRI theranostics: in vitro safety study in liver cells and macrophages
Authors SIMECKOVA, Pavlina (203 Czech Republic), Frantisek HUBATKA (203 Czech Republic), Jan KOTOUCEK (203 Czech Republic), Pavlina KNOTIGOVA TURANEK (203 Czech Republic), Josef MASEK (203 Czech Republic), Josef SLAVIK (203 Czech Republic), Ondrej KOVAC (203 Czech Republic), Jiri NECA (203 Czech Republic), Pavel KULICH (203 Czech Republic), Dominik HREBÍK (703 Slovakia, belonging to the institution), Jana STRASKA (203 Czech Republic), Katerina PENCIKOVA (203 Czech Republic), Jirina PROCHAZKOVA (203 Czech Republic), Pavel DIVIS (203 Czech Republic), Stuart MACAULAY (826 United Kingdom of Great Britain and Northern Ireland), Robert MIKULÍK (203 Czech Republic, belonging to the institution), Milan RASKA (203 Czech Republic), Miroslav MACHALA (203 Czech Republic) and Jaroslav TURÁNEK (203 Czech Republic, guarantor).
Edition Scientific reports, LONDON, NATURE PUBLISHING GROUP, 2020, 2045-2322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30224 Radiology, nuclear medicine and medical imaging
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.379
RIV identification code RIV/00216224:14110/20:00116364
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1038/s41598-020-60284-z
UT WoS 000562124000002
Keywords in English HEPARG CELLS; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; GENE-EXPRESSION; CONTRAST AGENTS; DTPA LIPOSOMES; TOXICITY; GRAPHENE; DISEASES; ENZYMES
Tags 14110127, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 8/9/2020 13:44.
Abstract
Gadolinium (Gd)-based contrast agents are extensively used for magnetic resonance imaging (MRI). Liposomes are potential nanocarrier-based biocompatible platforms for development of new generations of MRI diagnostics. Liposomes with Gd-complexes (Gd-lip) co-encapsulated with thrombolytic agents can serve both for imaging and treatment of various pathological states including stroke. In this study, we evaluated nanosafety of Gd-lip containing PE-DTPA chelating Gd+3 prepared by lipid film hydration method. We detected no cytotoxicity of Gd-lip in human liver cells including cancer HepG2, progenitor (non-differentiated) HepaRG, and differentiated HepaRG cells. Furthermore, no potential side effects of Gd-lip were found using a complex system including general biomarkers of toxicity, such as induction of early response genes, oxidative, heat shock and endoplasmic reticulum stress, DNA damage responses, induction of xenobiotic metabolizing enzymes, and changes in sphingolipid metabolism in differentiated HepaRG. Moreover, Gd-lip did not show pro-inflammatory effects, as assessed in an assay based on activation of inflammasome NLRP3 in a model of human macrophages, and release of eicosanoids from HepaRG cells. In conclusion, this in vitro study indicates potential in vivo safety of Gd-lip with respect to hepatotoxicity and immunopathology caused by inflammation.
PrintDisplayed: 20/4/2024 04:01